FDA/Industry Cooperation Evidenced In "Real Time" Reviews, IDE Approvals
This article was originally published in The Gray Sheet
Executive Summary
Manufacturer interest in FDA's "real time" review program for supplemental PMA applications increased during FDA's fiscal year 1998, yielding reduced agency review times, according to the Office of Device Evaluation's recently released annual report.